# Setmelanotide for acquired hypothalamic obesity: TRANSCEND

Source: https://pepvault.app/research/setmelanotide-transcend-2026

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Setmelanotide](https://pepvault.app/research#setmelanotide)

Randomized trial · people

# Setmelanotide: 16.5% BMI drop at 52 weeks in hypothalamic obesity

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

For obesity caused by hypothalamic damage, this year-long placebo-controlled trial adds evidence that setmelanotide lowered BMI and hunger, with more side effects, including serious ones, than placebo.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 120
- **Published:** 2026
- **Journal:** N Engl J Med

## What they tested

The team tested whether daily setmelanotide lowers BMI and hunger more than placebo in people whose obesity followed a hypothalamic tumor, lesion or injury.

## How the study was done

A phase 3, randomized, placebo-controlled trial in 120 people aged 4 to 66 with acquired hypothalamic obesity: 81 got setmelanotide and 39 got placebo (a dummy shot), given once daily under the skin. Treatment ran for 52 weeks after a dose-escalation period, with trial doses of 1.5 to 3.0 mg.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking setmelanotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

BMI (body-mass index, weight relative to height) changed by -16.5% on setmelanotide and by 3.3% on placebo at 52 weeks (P<0.001). In participants aged 12 and older, the weekly average of peak daily hunger, scored 0 to 10, fell by 2.73 points on setmelanotide and by 1.45 points on placebo (P = 0.009). Adverse events occurred in 100% of the setmelanotide group and 90% of the placebo group, and serious adverse events in 28% and 8%. The most common side effects on setmelanotide were skin darkening (hyperpigmentation), nausea, vomiting and headache.

## What it doesn’t show

The trial lasted 52 weeks and included only people with obesity after hypothalamic damage, so it does not show longer-term effects or results in other kinds of obesity. Hunger was measured only in those aged 12 and older, and the trial was funded by Rhythm Pharmaceuticals.

## The paper

Miller et al. Setmelanotide for the Treatment of Acquired Hypothalamic Obesity. N Engl J Med. 2026.

- [PubMed (PMID 42418774)](https://pubmed.ncbi.nlm.nih.gov/42418774/)
- [The paper (DOI 10.1056/NEJMoa2512275)](https://doi.org/10.1056/NEJMoa2512275)
- [ClinicalTrials.gov (NCT05774756)](https://clinicaltrials.gov/study/NCT05774756)

## The compound

- [Setmelanotide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/setmelanotide)
- [Setmelanotide dose guide](https://pepvault.app/lab/dosage/setmelanotide)

## With this study

### Setmelanotide

- [Setmelanotide: the full reference](https://pepvault.app/peptides/setmelanotide)
- [Setmelanotide dose guide](https://pepvault.app/lab/dosage/setmelanotide)

### Studies

- [Setmelanotide: injection-site reactions in 96% in pooled trials](https://pepvault.app/research/setmelanotide-sridharan-2026)
- [Setmelanotide: patients reported less hunger, more energy in TRANSCEND](https://pepvault.app/research/setmelanotide-transcend-2026-42528856)
- [All 8 studies](https://pepvault.app/research#setmelanotide)

### Compared with

- [PT-141 vs Setmelanotide](https://pepvault.app/peptides/compare/pt-141-vs-setmelanotide)
- [Melanotan II vs Setmelanotide](https://pepvault.app/peptides/compare/melanotan-ii-vs-setmelanotide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Body mass index (BMI)](https://pepvault.app/glossary/bmi)

## More studies on Setmelanotide

- [Setmelanotide: injection-site reactions in 96% in pooled trials](https://pepvault.app/research/setmelanotide-sridharan-2026) Meta-analysis · people · 2026
- [Setmelanotide: patients reported less hunger, more energy in TRANSCEND](https://pepvault.app/research/setmelanotide-transcend-2026-42528856) Clinical trial · people · 2026
- [Setmelanotide: mean BMI fell 18% at 52 weeks in ages 2-5 (VENTURE)](https://pepvault.app/research/setmelanotide-venture-2025) Clinical trial · people · 2025
- [Setmelanotide: 15% mean BMI drop at 16 weeks in hypothalamic obesity](https://pepvault.app/research/setmelanotide-roth-2024) Clinical trial · people · 2024
- [Setmelanotide: quality of life rose after 52 weeks in Bardet-Biedl](https://pepvault.app/research/setmelanotide-forsythe-2023) Clinical trial · people · 2023
- [Setmelanotide: 80% (POMC) and 45% (LEPR) lost at least 10% weight](https://pepvault.app/research/setmelanotide-clement-2020) Clinical trial · people · 2020
- [Every study on Setmelanotide](https://pepvault.app/research#setmelanotide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking setmelanotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking setmelanotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Setmelanotide

- [Setmelanotide: the full reference](https://pepvault.app/peptides/setmelanotide)
- [Setmelanotide dose guide](https://pepvault.app/lab/dosage/setmelanotide)

### Studies

- [Setmelanotide: injection-site reactions in 96% in pooled trials](https://pepvault.app/research/setmelanotide-sridharan-2026)
- [Setmelanotide: patients reported less hunger, more energy in TRANSCEND](https://pepvault.app/research/setmelanotide-transcend-2026-42528856)
- [All 8 studies](https://pepvault.app/research#setmelanotide)

### Compared with

- [PT-141 vs Setmelanotide](https://pepvault.app/peptides/compare/pt-141-vs-setmelanotide)
- [Melanotan II vs Setmelanotide](https://pepvault.app/peptides/compare/melanotan-ii-vs-setmelanotide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Body mass index (BMI)](https://pepvault.app/glossary/bmi)

<!--promo-->

PepVault for iPhone

## Taking setmelanotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Setmelanotide](https://pepvault.app/research#setmelanotide)

## The library

- [Setmelanotide](https://pepvault.app/peptides/setmelanotide)
- [Setmelanotide dose guide](https://pepvault.app/lab/dosage/setmelanotide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
